603669 灵康药业
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)3.347-27.803-15.377-14.668-15.104
总资产报酬率 ROA (%)1.893-16.362-9.081-8.707-8.964
投入资产回报率 ROIC (%)2.190-19.197-10.029-9.094-9.260

边际利润分析
销售毛利率 (%)41.31343.71346.88146.67267.809
营业利润率 (%)8.486-60.770-33.906-75.690-65.226
息税前利润/营业总收入 (%)12.574-40.554-33.207-76.447-65.670
净利润/营业总收入 (%)8.200-59.922-34.431-76.967-67.711

收益指标分析
经营活动净收益/利润总额(%)121.24086.85667.780103.96389.066
价值变动净收益/利润总额(%)-21.0641.5395.3399.6284.300
营业外收支净额/利润总额(%)-1.855-1.271-0.8141.3080.069

偿债能力分析
流动比率 (X)1.2161.0982.6753.6263.743
速动比率 (X)1.0510.9222.5483.3933.581
资产负债率 (%)42.93843.95638.68142.69038.849
带息债务/全部投入资本 (%)33.31034.20026.49839.19036.010
股东权益/带息债务 (%)197.877189.971274.441153.346176.783
股东权益/负债合计 (%)132.896127.500158.526134.249157.405
利息保障倍数 (X)2.963-2.085-78.049-310.910164.745

营运能力分析
应收账款周转天数 (天)191.645278.698145.938143.506134.245
存货周转天数 (天)95.213110.97675.527181.612194.865